| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6242088 | Respiratory Medicine | 2011 | 10 Pages |
Abstract
Inhaled FP500 monotherapy was associated with consistent and clinically important improvements in FEV1, static lung volumes, dynamic operating lung volumes, and exercise endurance when added to established maintenance long-acting bronchodilator therapy in patients with moderate to severe COPD.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Jordan A. Guenette, Natya Raghavan, Veronica Harris-McAllister, Megan E. Preston, Katherine A. Webb, Denis E. O'Donnell,